CanSino Biologics Inc. (FRA:CJH)

CanSino Biologics Statistics

Total Valuation

FRA:CJH has a market cap or net worth of EUR 1.50 billion. The enterprise value is 1.34 billion.

Market Cap	1.50B
Enterprise Value	1.34B

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	132.67M
Shares Outstanding	n/a
Shares Change (YoY)	-1.66%
Shares Change (QoQ)	-40.81%
Owned by Insiders (%)	31.39%
Owned by Institutions (%)	6.57%
Float	159.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	51.96
PS Ratio	12.93
PB Ratio	2.55
P/TBV Ratio	2.65
P/FCF Ratio	n/a
P/OCF Ratio	81.80
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-78.78
EV / Sales	11.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-71.45

Financial Position

The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.29.

Current Ratio	3.62
Quick Ratio	3.24
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-9.10
Interest Coverage	-4.67

Financial Efficiency

Return on equity (ROE) is -2.84% and return on invested capital (ROIC) is -2.11%.

Return on Equity (ROE)	-2.84%
Return on Assets (ROA)	-1.87%
Return on Invested Capital (ROIC)	-2.11%
Return on Capital Employed (ROCE)	-3.68%
Revenue Per Employee	105,290
Profits Per Employee	-15,388
Employee Count	1,105
Asset Turnover	0.13
Inventory Turnover	0.71

Taxes

Income Tax	-595,950
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.50%
50-Day Moving Average	5.13
200-Day Moving Average	4.36
Relative Strength Index (RSI)	37.09
Average Volume (20 Days)	83

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:CJH had revenue of EUR 116.35 million and -17.00 million in losses. Loss per share was -0.07.

Revenue	116.35M
Gross Profit	86.38M
Operating Income	-27.37M
Pretax Income	-17.60M
Net Income	-17.00M
EBITDA	-10.11M
EBIT	-27.37M
Loss Per Share	-0.07

Balance Sheet

The company has 334.15 million in cash and 170.65 million in debt, giving a net cash position of 163.50 million.

Cash & Cash Equivalents	334.15M
Total Debt	170.65M
Net Cash	163.50M
Net Cash Per Share	n/a
Equity (Book Value)	590.38M
Book Value Per Share	3.23
Working Capital	341.36M

Cash Flow

In the last 12 months, operating cash flow was 18.39 million and capital expenditures -37.14 million, giving a free cash flow of -18.75 million.

Operating Cash Flow	18.39M
Capital Expenditures	-37.14M
Free Cash Flow	-18.75M
FCF Per Share	n/a

Margins

Gross margin is 74.24%, with operating and profit margins of -23.53% and -14.62%.

Gross Margin	74.24%
Operating Margin	-23.53%
Pretax Margin	-15.13%
Profit Margin	-14.62%
EBITDA Margin	-8.69%
EBIT Margin	-23.53%
FCF Margin	n/a

Dividends & Yields

FRA:CJH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.66%
Shareholder Yield	1.66%
Earnings Yield	-1.13%
FCF Yield	-1.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:CJH has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.

Altman Z-Score	3.12
Piotroski F-Score	5